NO20025659L - Heterocykliske forbindelser - Google Patents
Heterocykliske forbindelserInfo
- Publication number
- NO20025659L NO20025659L NO20025659A NO20025659A NO20025659L NO 20025659 L NO20025659 L NO 20025659L NO 20025659 A NO20025659 A NO 20025659A NO 20025659 A NO20025659 A NO 20025659A NO 20025659 L NO20025659 L NO 20025659L
- Authority
- NO
- Norway
- Prior art keywords
- heterocyclic compounds
- heterocyclic
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000156936 | 2000-05-26 | ||
| PCT/JP2001/004400 WO2001090087A1 (fr) | 2000-05-26 | 2001-05-25 | Composes heterocycliques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20025659D0 NO20025659D0 (no) | 2002-11-25 |
| NO20025659L true NO20025659L (no) | 2002-11-25 |
Family
ID=18661643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20025659A NO20025659L (no) | 2000-05-26 | 2002-11-25 | Heterocykliske forbindelser |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US7144906B2 (no) |
| EP (2) | EP1295875A4 (no) |
| JP (1) | JP3591514B2 (no) |
| KR (1) | KR100545507B1 (no) |
| CN (1) | CN1238347C (no) |
| AU (2) | AU5884101A (no) |
| BR (1) | BR0111199A (no) |
| CA (1) | CA2410382A1 (no) |
| HU (1) | HUP0302397A3 (no) |
| IL (1) | IL152979A0 (no) |
| MX (1) | MXPA02011609A (no) |
| NO (1) | NO20025659L (no) |
| RU (1) | RU2259361C2 (no) |
| UA (1) | UA72625C2 (no) |
| WO (1) | WO2001090087A1 (no) |
| ZA (1) | ZA200209152B (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004099173A1 (en) * | 2003-05-12 | 2004-11-18 | Theracarb Inc. | Multivalent inhibitors of serum amyloid p component |
| EP1479677A1 (en) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | New indole derivatives as factor xa inhibitors |
| CN1849317A (zh) * | 2003-09-12 | 2006-10-18 | 日本新药株式会社 | 杂环化合物的结晶 |
| AP2006003688A0 (en) * | 2004-01-09 | 2006-08-31 | Cadila Healthcare Ltd | 1,3-dioxane derivatives and analogues thereof useful in the treatment of I.A obesity and diabetes |
| WO2006018855A1 (en) * | 2004-08-20 | 2006-02-23 | Cadila Healthcare Limited | Novel antidiabetic compounds |
| WO2006030892A1 (ja) * | 2004-09-17 | 2006-03-23 | Nippon Shinyaku Co., Ltd. | 複素環化合物の製造方法 |
| WO2007096261A2 (en) * | 2006-02-21 | 2007-08-30 | F. Hoffmann-La Roche Ag | Process for the preparation of dioxane derivatives |
| EP2104666A4 (en) * | 2007-01-08 | 2011-05-25 | Seoul Nat Univ Ind Foundation | THIAZOL COMPOUND (AS PPAR DELTA LIGAND), AND PHARMACEUTICAL, COSMETIC AND HEALTHY FOOD THEREOF |
| CA2744985C (en) | 2008-12-01 | 2014-05-06 | Mitsubishi Tanabe Pharma Corporation | Carboxylic acid derivative containing thiazole ring useful for the prevention or treatment of hyperlipidemia |
| MX366137B (es) * | 2009-05-08 | 2019-06-28 | Pronova Biopharma Norge As | Acidos grasos poliinsaturados para el tratamiento de trastornos relacionados a las areas de los trastornos cardiovasculares, metabolicos e inflamatorios. |
| EA201270492A1 (ru) * | 2009-10-01 | 2012-11-30 | Кадила Хелзкэр Лимитед | Соединения для лечения дислипидемии и связанных с ней заболеваний |
| BR112019015191A2 (pt) * | 2017-01-24 | 2020-03-24 | Alphala Co., Ltd. | Compostos de amida e uso dos mesmos |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1473212A (en) * | 1974-02-27 | 1977-05-11 | Wyeth John & Brother Ltd | Thiazolylmethyl acetic acid derivatives methods for their preparation and compositions containing them |
| JPS60208971A (ja) * | 1984-03-30 | 1985-10-21 | Hisamitsu Pharmaceut Co Inc | 新規なオキサゾ−ル誘導体 |
| ZW19786A1 (en) * | 1985-10-17 | 1988-05-18 | Hoffmann La Roche | Heterocyclic compounds |
| FR2699172B1 (fr) | 1992-12-11 | 1995-01-20 | Adir | Nouveaux dérivés de 4-méthyl-1,3-oxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
| US5614544A (en) * | 1993-09-14 | 1997-03-25 | Takeda Chemical Industries, Ltd. | Oxazolidinedione derivatives and their use |
| WO1999031056A1 (fr) * | 1997-12-12 | 1999-06-24 | Toyama Chemical Co., Ltd. | Derives d'ether alcoylique ou leurs sels, et antagonistes du calcium les contenant |
| ATE451346T1 (de) * | 1998-03-10 | 2009-12-15 | Ono Pharmaceutical Co | Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten |
| WO2000012491A1 (fr) * | 1998-08-27 | 2000-03-09 | Ono Pharmaceutical Co., Ltd. | Derives d'acide carboxylique et medicaments dont ils sont le principe actif |
| US6589969B1 (en) * | 1998-10-16 | 2003-07-08 | Ono Pharmaceutical Co., Ltd. | Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| GB0031109D0 (en) * | 2000-12-20 | 2001-01-31 | Glaxo Group Ltd | Chemical compounds |
| GB0031107D0 (en) | 2000-12-20 | 2001-01-31 | Glaxo Group Ltd | Chemical compounds |
| CN100356917C (zh) * | 2001-05-15 | 2007-12-26 | 霍夫曼-拉罗奇有限公司 | 用作糖尿病治疗中的PPAR－α和PPAR－γ激活剂的羧酸取代的噁唑衍生物 |
| ATE347890T1 (de) * | 2001-08-31 | 2007-01-15 | Sanofi Aventis Deutschland | Diarylcycloalkylderivate, verfahren zu ihrer herstellung und ihre verwendung als ppar- aktivatoren |
| US6716842B2 (en) * | 2002-04-05 | 2004-04-06 | Warner-Lambert Company, Llc | Antidiabetic agents |
-
2001
- 2001-05-25 RU RU2002135079/04A patent/RU2259361C2/ru not_active IP Right Cessation
- 2001-05-25 HU HU0302397A patent/HUP0302397A3/hu unknown
- 2001-05-25 EP EP01932267A patent/EP1295875A4/en not_active Withdrawn
- 2001-05-25 BR BR0111199-0A patent/BR0111199A/pt not_active IP Right Cessation
- 2001-05-25 UA UA2002129620A patent/UA72625C2/uk unknown
- 2001-05-25 MX MXPA02011609A patent/MXPA02011609A/es not_active Application Discontinuation
- 2001-05-25 WO PCT/JP2001/004400 patent/WO2001090087A1/ja not_active Application Discontinuation
- 2001-05-25 KR KR1020027016023A patent/KR100545507B1/ko not_active IP Right Cessation
- 2001-05-25 AU AU5884101A patent/AU5884101A/xx active Pending
- 2001-05-25 CN CNB018101402A patent/CN1238347C/zh not_active Expired - Fee Related
- 2001-05-25 EP EP05018610A patent/EP1634876A3/en not_active Withdrawn
- 2001-05-25 CA CA002410382A patent/CA2410382A1/en not_active Abandoned
- 2001-05-25 AU AU2001258841A patent/AU2001258841B2/en not_active Ceased
- 2001-05-25 IL IL15297901A patent/IL152979A0/xx unknown
- 2001-05-25 US US10/276,670 patent/US7144906B2/en not_active Expired - Fee Related
- 2001-05-25 JP JP2001586275A patent/JP3591514B2/ja not_active Expired - Fee Related
-
2002
- 2002-11-11 ZA ZA200209152A patent/ZA200209152B/en unknown
- 2002-11-25 NO NO20025659A patent/NO20025659L/no not_active Application Discontinuation
-
2004
- 2004-02-17 US US10/781,293 patent/US7030143B2/en not_active Expired - Fee Related
- 2004-02-17 US US10/781,433 patent/US7022723B2/en not_active Expired - Fee Related
- 2004-02-17 US US10/781,475 patent/US6998412B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20050009892A1 (en) | 2005-01-13 |
| EP1295875A4 (en) | 2004-05-06 |
| UA72625C2 (uk) | 2005-03-15 |
| US6998412B2 (en) | 2006-02-14 |
| US7030143B2 (en) | 2006-04-18 |
| CN1238347C (zh) | 2006-01-25 |
| NO20025659D0 (no) | 2002-11-25 |
| BR0111199A (pt) | 2003-04-01 |
| KR100545507B1 (ko) | 2006-01-24 |
| HUP0302397A2 (hu) | 2003-11-28 |
| US20050009785A1 (en) | 2005-01-13 |
| CA2410382A1 (en) | 2002-11-25 |
| JP3591514B2 (ja) | 2004-11-24 |
| EP1295875A1 (en) | 2003-03-26 |
| US20030166697A1 (en) | 2003-09-04 |
| EP1634876A2 (en) | 2006-03-15 |
| MXPA02011609A (es) | 2003-03-27 |
| CN1430612A (zh) | 2003-07-16 |
| WO2001090087A1 (fr) | 2001-11-29 |
| EP1634876A3 (en) | 2007-03-14 |
| IL152979A0 (en) | 2003-06-24 |
| KR20030019399A (ko) | 2003-03-06 |
| AU5884101A (en) | 2001-12-03 |
| US20040162325A1 (en) | 2004-08-19 |
| AU2001258841B2 (en) | 2005-06-23 |
| RU2259361C2 (ru) | 2005-08-27 |
| ZA200209152B (en) | 2004-02-11 |
| US7022723B2 (en) | 2006-04-04 |
| US7144906B2 (en) | 2006-12-05 |
| HUP0302397A3 (en) | 2007-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20026196L (no) | Kinazolinditosylatsalt-forbindelser | |
| DK1619192T3 (da) | Arylkondeserede azapolycykliske forbindelser | |
| AR027983A1 (es) | Novedosos compuestos | |
| DE50114491D1 (de) | Substituierte C-Cyclohexylmethylamin-Derivative | |
| NO20025659L (no) | Heterocykliske forbindelser | |
| PT1299356E (pt) | Novos compostos | |
| ATE282021T1 (de) | Substituierte aminomethyl-phenyl- cyclohexanderivate | |
| DE50103035D1 (de) | Substituierte 1-aminobutan-3-ol-derivate | |
| ATE372338T1 (de) | Deshalogenverbindungen | |
| AR028220A1 (es) | Novedosos compuestos | |
| NO20023954D0 (no) | Substituerte piperasinforbindelser | |
| NO20031837L (no) | Kalsilytiske forbindelser | |
| NO20030303L (no) | Kalsilytiske forbindelser | |
| NO20023508L (no) | Kalsilyttiske forbindelser | |
| DE50112454D1 (de) | Substituierte 5-amino-1-penten-3-ol-derivate | |
| AR028399A1 (es) | Nuevos compuestos | |
| ATE360010T1 (de) | Heterocyclische retioidverbindungen | |
| SE0003477D0 (sv) | Compounds | |
| SE0000263D0 (sv) | New compounds | |
| AR027949A1 (es) | Novedosos compuestos | |
| IS8574A (is) | Ný efnasambönd | |
| SE0002788D0 (sv) | New compounds | |
| SE0003640D0 (sv) | New compounds | |
| SE0001804D0 (sv) | New compounds II | |
| SE0004611D0 (sv) | Novel Compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |